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Available online xxxxHuman immunodeﬁciency virus type 1 (HIV-1) was discovered in the early 1980s when the virus had already
established a pandemic. For at least three decades the epidemic in the Western World has been dominated by
subtype B infections, as part of a sub-epidemic that traveled from Africa through Haiti to United States. However,
the pattern of the subsequent spread still remains poorly understood. Herewe analyze a large dataset of globally
representative HIV-1 subtype B strains to map their spread around the world over the last 50 years and describe
signiﬁcant spread patterns.We show that subtype B travelled fromNorth America toWestern Europe in different
occasions, while Central/Eastern Europe remained isolated for the most part of the early epidemic. Looking with
more detail in European countries we see that the United Kingdom, France and Switzerland exchanged viral iso-
lates with non-European countries thanwith European ones. The observed pattern is likely tomirror geopolitical
landmarks in the post-World War II era, namely the rise and the fall of the Iron Curtain and the European colo-
nialism. In conclusion, HIV-1 spread through speciﬁcmigration routeswhich are consistent with geopolitical fac-
tors that affected human activities during the last 50 years, such as migration, tourism and trade. Our ﬁndings
support the argument that epidemic control policies should be global and incorporate political and socioeconom-
ic factors.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
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Migration1. Introduction
Human immunodeﬁciency virus (HIV) was discovered in the early
1980s (Barre-Sinoussi et al., 1983) when the virus had already
established a pandemic. For at least three decades the epidemic in the
Western World has been dominated by subtype B infections, as part of
a sub-epidemic that traveled from Africa to United States through
Haiti, and then to the rest of the world (Gilbert et al., 2007). Archival
HIV sequences from the earliest known Haitian AIDS patients have
helped science to understand early events in the spread of HIV
(Gilbert et al., 2007). Genetic analysis of the epidemiologically homoge-
nous epidemic in the UnitedKingdom(UK) amongmenhaving sexwith
men (MSM) has revealed multiple introductions of the virus to the
country and distinct subepidemics (Hue et al., 2005). Within Europe it
has been previously indicated that major tourist destinations have
served as transmission outwards (Paraskevis et al., 2009), and also, as
expected, neighboring countries are more likely to exchange viral
strains than distant countries (Frentz et al., 2013). However, with the
exception of local country-speciﬁc outbreaks and studies tracking the
spread of the virus on a local scale, the global ﬂow of subtype B during
the last 30 years still remains to be charted.
With 0.3 mutations per genome per replication cycle in vitro
(Mansky and Temin, 1995) and almost 40 mutations per genome per
replication cycle in vivo (Cuevas et al., 2015) HIV-1 is among the fastest
evolving humanpathogens. Since the humanhost evolvesmuch slower,
pathogen-host evolutionary conﬂicts have not, yet visibly affected the
host. HIV-1 has been infecting humans for less than 100 years, and
mathematical models of the effect of HIV on human gene frequency in-
dicate that it is unlikely to have shaped our evolution on these time-
scales (Cromer et al., 2010). On the other hand, large-scale human
activity should be reﬂected in the global spread and evolutionary pat-
terns of the virus (host-to-parasite) as it has been documented for
other pathogens (Paraskevis et al., 2013). Available molecular se-
quences of the virus are an invaluable archive of the history of the epi-
demic. Quantifying the viral ﬂows generates hypotheses to be tested
and assessed on the potential effects of international public health
measures.
HIV-1 has been extensively sequenced within part of the pol gene
(protease, reverse transcriptase and integrase) mostly because this re-
gion harbors resistance mutations against the most commonly used
antiretrovirals (protease, reverse transcriptase and integrase inhibitors)
(Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014;
Rhee et al., 2003; Society, E.A.C., 2012; Vandamme et al., 2011). Despite
the abundance of available viral sequences there is no large-scale sys-
tematicmolecular surveillance of HIV-1 spread becausemost sequences
are produced as part of routine clinical care and never published or de-
posited in public sequence databases.We thus set out to build a globallyal., The global spread of HIV-1representative HIV-1 subtype B dataset of pol gene sequences from pre-
vious studies after a systematic search of the literature. Our aim is to
clarify the global routes of the epidemic and understand how these
were inﬂuenced by human activities over the last 50 years.
2. Materials and methods
2.1. Systematic collection of molecular sequences
2.1.1. Non-European dataset
We collected non-European HIV-1 subtype B sequences, through a
systematic bibliographic search in PubMed searching for molecular ep-
idemiology or antiretroviral resistance studies for each country. We
used the following keywords for the bibliographic search: “HIV-1”, “mo-
lecular epidemiology”, “resistance”, “subtype B” and “pol” in different
combinations. We subsequently selected subtype B sequences from
the retrieved studies to maximise representativeness and geographic
coverage both globally and within each country. More details on the
bibliographic search, collection and selection of sequences are available
in Supplementary Information (SI).
2.1.2. European dataset
The European dataset included sequences from two different
sources: the Combined Analysis of Resistance Transmission over Time
of Chronically and Acute InfectedHIV Patients (CATCH) and the SPREAD
(Strategy to Control SPREAD of HIV Drug Resistance) collaboration. The
CATCH study included 2208 antiretroviral naïve individuals from 18 Eu-
ropean countries and Israel during 1996–2002 (Wensing et al., 2005).
Of those, 1601 were newly diagnosed cases and 607 were chronically
infected patients, included in a retrospective setting. The prevalence of
subtype B was 70% among the CATCH population (Wensing et al.,
2005). Notably, although these data for 1996–2002 were retrospective-
ly selected and pooled, they were originally collected as part of national
surveillance studies of the transmission of drug resistance or as part of
the standard clinical practice of baseline sequencing for all newly diag-
nosed cases in each participating center (Wensing et al., 2005). The
SPREAD study included 4480 newly diagnosed patients sampled during
9/2002–12/2007 from 20 European countries and Israel. In the prospec-
tive setting a standardised sampling strategy was designed to include
representative sampling from all countries (Vercauteren et al., 2009;
Wensing et al., 2008). For the purpose of this study we included only
those classiﬁed as subtype B from both the CATCH and the SPREAD
studies.
In both studies all patients were older than 18 years and had not re-
ceived antiretroviral therapy. More details on the sampling strategies
have been published previously (Vercauteren et al., 2009; Wensing et
al., 2005, 2008). The sampling countries and the number of sequencessubtype B epidemic, Infection, Genetics and Evolution (2016), http://
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plemental material.
2.2. Details of the phylogeographic analyses
2.2.1. Multiple sequence alignments and phylogenetic analysis
We aligned the HIV-1 sequences using ClustalW (version 1.82) and
then manually corrected the alignment according to the encoded read-
ing frame using MEGA5 (Hall, 2013). To avoid potential biases to our
analysis resulting from convergent evolution due to selection of resis-
tant isolates by antiretroviral treatment, we discarded codon positions
known to confer antiretroviral resistance (PR: 30, 32, 33, 46, 47, 48,
50, 54, 76, 82, 84, 88, 90, and RT: 41, 62, 65, 67, 69, 70, 74, 75, 77, 100,
103, 106,108, 115, 116, 151, 181, 184, 188, 190, 210, 215, 219, 225,
236) (Lewis et al., 2008). The ﬁnal alignment consisted of 222 codons
and covers positions 2283–3191 of the HXB2 strain.
We estimated a phylogenetic tree from the nucleotide sequence
alignment using ML under the general time-reversible (GTR) model of
nucleotide substitution, including a G distributed rate of heterogeneity
among sites as implemented in RAxML (Stamatakis, 2006; Stamatakis
et al., 2008). We also estimated ML trees on 250 bootstrapped align-
ments to use on our subsequent phylogeographic analysis. We didn't
use a higher number of bootstrap replicates because the calculations
would be computationally expensive. Trees were rooted at the
midpoint.
2.2.2. Phylogeographic analyses
We used the bootstrap trees to estimate HIV-1 migration events
among geographic regions with the parsimony approach described by
Slatkin and Maddison, as implemented in PAUP* 4.0 (Slatkin and
Maddison, 1989). Speciﬁcally, we assigned the tips of the inferred
trees with a character according to the geographic origin of the patient
(e.g. 0, 1, 2 for Austria, Belgium, Denmark, respectively, etc.). The viral
migration events between different areas were estimated by DELTRAN
optimization using only unambiguously reconstructed ancestral states.
We provide more details in SI.
We were not able to implement a method that combines molecular
clock and phylogeography such as the one used in BEAST; the large
number of geographic regions along with the higher number of se-
quences make the analysis to be extremely computationally intensive
(Lemey et al., 2009) and the sampling of the Bayesian Markov Chains
did not converge (data not shown). On the other hand, a signiﬁcant pro-
portion of the sequences do not have isolation date, thus for a combined
molecular clock-phylogeographic analysis we would have to discard a
signiﬁcant amount of our dataset reducing the representativeness of
our sampling. Consequently, given that previous comparisons between
parsimony and Bayesian analyses showed that a parsimony-based ap-
proach provides reasonably similar scenarios of geographic migration
(Lemey et al., 2009) and have been widely used for similar analyses
(Angelis et al., 2015; Paraskevis et al., 2009; Wallace et al., 2007), we
chose the parsimony approach because it is feasible and provides rea-
sonably accurate results by taking advantage of themost representative
dataset.
2.2.3. Steps of analysis
We performed the following phylogeographic analyses to identify
viral transmission pathways:
1) Viral migration between large geographic areas. We grouped the
viral strains in geographic areas, namely North America, Europe,
Central & South America, Caribbean, Africa, Asia and Oceania. Since
subtype B has a very low prevalence in many non-Western coun-
tries, the geographical regions of Africa, Asia and Oceania could not
be further subdivided due to a lack of available sequences. We
should note that in terms of the global HIV-1 epidemiology it
would make sense to further split some geographic regionsPlease cite this article as: Magiorkinis, G., et al., The global spread of HIV-1
dx.doi.org/10.1016/j.meegid.2016.05.041(similarly to North and South America), for example Africa could
be split into North and sub-Saharan regions. However, subtype B
has very low prevalence in non-Western countries resulting into
low availability of sequences from these areas. Thus, we did not seg-
regate further these regions, as it would then diminish statistical
power. We provide detailed geographic sampling of the sequences
in Table S1 and we pinpoint that spread inferences in low-preva-
lence geographic regions should be interpreted with caution not to
generalize the result over the full geographic region, but to think of
them as proxies of the global viral ﬂow around the world (SI).
2) We repeated the above analysis by dividing Europe into Western
and Central/Eastern Europe (WHO criteria) (see SI).
3) Viralmigration between geographic areas (North America, Central &
South America, Caribbean, Africa, Asia, Oceania) and European
countries.
4) Viral migration within Europe. Only the European viral strains were
used to infer migration routes among the European countries.
2.2.4. Statistical phylogeography: taking into account sources of uncertain-
ty in inferring migration events
We estimated which migration pathways were signiﬁcantly differ-
ent from the expected pathways under the null hypothesis of full
geographic mixing (panmixis) of HIV-1 sequences. Thus, signiﬁcance
becomes independent from prevalence, and countries with a larger
number of migration events can have non-signiﬁcant migration if they
have a high prevalence. Signiﬁcance was established when the distribu-
tion of the migration events inferred from the 250 bootstrap trees was
statistically different from the distribution of the events inferred from
the same set of trees (N = 250) in each pathway after randomly
reshufﬂing taxa at the tips as described previously (Angelis et al.,
2015; Paraskevis et al., 2009). In a full geographicmixing case, an infect-
ed individual would have the same probability to transmit the HIV-1 to
any other healthy individual, and all individuals are just as likely to
share closely related viruses. Thus, a random reshufﬂing of taxa at the
tips would simulate a tree inferred from such a population. The
reshufﬂing was performed in the Mesquite program (Maddison and
Maddison, 2015).We assessed equality of means between the observed
and the expected migration events by means of one-sided Mann–
Whitney test and adjusted the level of signiﬁcance according to
Bonferroni correction for multiple comparisons (for 32 localities we
have 992 possible pathways/comparisons). We ﬁnally estimated the
ratio between the observed and the expected value under the panmixis
hypothesis (referred to as observed/expected ratio), which provides a
quantitativemetric of the relative spread of the virus between countries
correcting for potential sampling bias due to unequal number of strains
per country. Higher ratios suggest higher levels of viral exchange among
locations.We randomly down-sampled (datasets I and II, see SI) and re-
peated all analyses (1) - (4) twice to assess robustness of the results.
Only results from the ﬁrst run are reported.
2.2.5. Force of migration: a summary migration index
We summarize the exporting and importingmigration for each geo-
graphic region using a newmetricwhichwe call Force ofMigration (FM)
and is deﬁned as:
FM ¼ ME  EMI  I ;
where E is the number of signiﬁcantly exporting pathways that a region
has, ME is the total number of migration events from these exporting
pathways, I is the number of signiﬁcantly importing pathways that the
region has and MI is the total number of migration events from those
importing pathways.
To create null distribution of migration indexes we have generated
phylogeographic matrices from the randomly reshufﬂed (panmictic)
phylogenies as described above (randomly-generated matrices). Thesesubtype B epidemic, Infection, Genetics and Evolution (2016), http://
4 G. Magiorkinis et al. / Infection, Genetics and Evolution xxx (2016) xxx–xxxpanmictic matrices represent the case where the sequences included in
the phylogenies do not come from a geographic structure, thus the ob-
served migration can be simply explained by free randommove within
the same locality. To estimate the distribution of FMwe compare each of
the bootstrap-generated migration matrices with one randomly select-
edmatrix from the set of the randomly-generatedmatrices. If a cell (mi-
gration counts) of the bootstrap-generated matrix contains more
migration events than the respective cell of the randomly-generated
matrix we consider it to be signiﬁcant and include it in the calculation
of the FM. We thus obtain 250 FM values (for each geographic region),
which correspond to the distribution of the observed FM. To generate a
null distribution of FM values we compare each one of randomly-gener-
ated matrices against a randomly chosen matrix from the rest of the
randomly-generated matrices. We thus obtain 250 FM values (for each
geographic region), which correspond to the null (expected) distribu-
tion of FM. We test if the observed values of FM differ signiﬁcantly
from the expected distribution of FM by means of the Mann–Whitney
test taking into account multiple comparisons (Bonferroni correction).
We use this metric to classify whether a geographical unit is actively
spreading (“outward”) or passively receiving (“inward”) the subtype B
epidemic.
2.2.6. Non-European connectivity index
To estimate if a Western European country is more connected with
non-European regions than expected we calculate for each Western
European country an out-of-Europe export index as follows:
Cn ¼ total number of significant migration events to non‐European targetsð Þtotal number of significant migration events to European targetsð Þ
We calculate this index for the observed and the expected
(bootstrapped) phylogeographies and then we statistically test using a
Mann–Whitney test if the observed index is higher than the expected
(this being equivalent to testing whether the ratio of the observed/ex-
pected is higher than 1). For simplicity we summarized the propensity
to export more by producing the ratio of the observed Cn versus the ex-
pected Cn (Fig. S4 in the supplemental material); ratio higher than 1
means the country exportsmore to non-European regions than to Euro-
peans than randomly expected.
2.3. Molecular clock analysis
We estimated the time to Most Recent Common Ancestor (tMRCA)
for ﬁve clusters of sequences from Central and Eastern Europe including
reference sequenceswith known sampling dates.We focused onmono-
phyletic clusters from C.E. European countries were geographically
deﬁned phylogenetic clusters including ≥75%of sequences fromC.E. Eu-
rope. These clusters were selected in order to estimate the tMRCA of the
regional epidemics spreading in this area. To increase the samplingwin-
dow of sequences from C.E. Europe, we included 9 sequences sampled
from North America, Europe and Asia (sampling period between 1983
and 2004).We used a Bayesian approach as implemented in BEAST ver-
sion 1.8.0 (Drummond and Rambaut, 2007) with a GTR + G model of
nucleotide substitution. We used the uncorrelated lognormal relaxed
clock model (Drummond et al., 2006) with TipDates and a non-para-
metric coalescent approach (Bayesian skyline) (Drummond and
Rambaut, 2007). Markov chain Monte Carlo (MCMC) was run 2 times
for each cluster for 30× 106 generationswith a burn in of 30 × 105 sam-
pling every 1000 iterations. For the largest cluster (n=230 sequences)
MCMCwas run for 90× 106 generationswith a burn in of 20× 106, sam-
pling every 1000 generations. Convergence was assessed using Tracer
v1.5 (Rambaut et al., 2013-12-11) and an Estimated Sample Size (ESS)
larger than 200. The consensus tree for each run was estimated by the
TreeAnnotator program (Drummond and Rambaut, 2007).Please cite this article as: Magiorkinis, G., et al., The global spread of HIV-1
dx.doi.org/10.1016/j.meegid.2016.05.0413. Results
Weﬁrst use thenucleotide alignment to reconstruct thephylogenet-
ic relationships among viral strains. We take into account phylogenetic
uncertainty by estimating several phylogenetic trees viamaximum like-
lihood (ML) method using bootstrap resampling. We then assign geo-
graphic sampling information at the tips of the bootstrap trees and
reconstruct the pastmovement of the viral strains across the geographic
regions by estimating the number and direction of viral migration
events using parsimony (Slatkin and Maddison, 1989). We then use
this information to identify viral migration routes and test for their sta-
tistical signiﬁcance. Different geographical grouping strategies of the
viral strains are used in order to track the viral spread in different spatial
scales and to assess robustness of the inferred transmission patterns.
We also introduce new metrics to classify speciﬁc geographic regions
into “outward” (regions where HIV mostly departed from), “inward”
(regions that mostly received HIV) or “isolated” (regions where HIV ex-
change with other regions was much lower) and explore viral connec-
tivity links among particular areas. Finally we test our results for
epidemiological consistency and date sampling bias.
3.1. Source of data
We pooled HIV-1 pol gene sequences from three sources, two Euro-
pean cohort sequence databases (see European dataset inMaterials and
methods) and a dataset with publicly available sequences, whichwe se-
lected through a systematic search of the literature (see Non-European
dataset inMaterials andmethods) (Vercauteren et al., 2009;Wensing et
al., 2005, 2008). In total we collected 10,078 sequences from 78 coun-
tries representing the vast majority of countries that are affected by
the subtype B global pandemic (Table S4).
3.2. Patterns of regional clustering inferred by phylogenetic analysis
We used our subtype B alignment (Dataset I, Table S1) to estimate a
ML phylogenetic tree and we colored its viral clades in different colors
according to sampling location in order to infer phylogenetic relation-
ships among viral strains from different sampling locations. The global
colored phylogeographic trees show that European strains tend to clus-
ter together, whereas North American strains are very dispersed among
the global genetic diversity (Fig. 1A). More speciﬁcally, 1787 HIV-1 se-
quences, that is 44% of the total European sampled population (N =
4020) (Fig. 1C), were included in a single clade; 71% of the sequences
in this large clade were sampled from Western Europe (N = 1274)
(Fig. 1A, Subcluster 1). We also detected another mainly European
clade, which included strains from both Western and Central/Eastern
Europe (Fig. 1A, Subcluster 2). Asian and Caribbean sequences showed
clustering patterns and formed several clades in away similar to Europe
(Fig. 1A). In contrast, North and Central & SouthAmerican lineageswere
widely distributed across the global phylogeny suggesting that HIV-1
spread is higher between these areas and the rest of the world. North
American strains tend to be closer to the root than groups of sequences
found in multiple other areas (i.e. shown in white and red color in
Fig. 1A and B, respectively). In the phylogeographic tree (Fig. 1C) with
isolates categorized in European and non-European groups we see
that European speciﬁc clades seem to be nested within non-European
founders.
A phylogeographic treemight only be suggestive of globalmigration
patterns and can provide only limited quantitative information of viral
spread among countries. Crucially, statistical support of clades with
bootstrap values in these trees is expected to be low due to the high
number of closely related sequences included in the analyses
(Sanderson and Wojciechowski, 2000), which does not allow for infer-
ence of source-sink patterns. Thus, in order to evaluate viral spread we
use a statistical phylogeography approach, which provides a formalsubtype B epidemic, Infection, Genetics and Evolution (2016), http://
Fig. 1.ML phylogeographic tree showing viral clades in different colors according to sampling area. A: Clades from eight different geographic areas are highlighted. B: Clades are separated
into North American and other regions and C: clades are separated into European and non-European. W. Europe: Western Europe, C.E. Europe: Central/Eastern Europe, C.S.·America:
Central and South America, N. America: North America.
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viral exchanges.
3.3. Tracing the spread of HIV-1 subtype B
In the following sectionswe identifymigration patterns of subtype B
around the globe bymeans of statistical phylogeography. To control for
potential sampling bias and quantify spread at different geographical
scales, we performed analyses with four levels of geographical segrega-
tion. We grouped viral strains according to: (1) large geographical
regions Europe, North America, Central/South America, Caribbean,
Africa, Asia and Oceania (WHO criteria), (2) as in (1) but splitting
Europe into Central/East andWestern Europe and (3) as in (1) but split-
ting Europe into countries and (4) grouping only European viral strains
by country to estimate viral migration only within Europe.
First, we comment on the migration routes arising from the statisti-
cally signiﬁcant migration events and then we test for epidemiological
consistency and robustness of results. Quantitative details (number of
migration events and statistical signiﬁcance of pathways) are provided
in Tables 1, 2 and Tables S2 and S3 in the supplemental material.
3.3.1. Global spread
Considering the global migration of HIV-1 subtype B between large
geographical regions. Europewas not a signiﬁcant “outward” of subtype
B towards other regions (Table 1 – “Europe” row has no statisticallyTable 1
Mean of observed migration events (1st row) across all bootstrap trees for each pathway an
geographic grouping strategy 1.
Importing to
N.·America C.S. America
Exporting from N.·America 175.27
3.82
C.S.·America 25.24
2.13
Caribbean 1.48 2.15
0.75 1.72
Africa 0.57 0.57
1.84 2.25
Asia 1.90 2.67
0.19 0.44
Oceania 0.48 0.65
0.95 1.76
Europe 147.67 100.34
0.18 0.23
Note. Cells in bold indicate statistically signiﬁcant pathways (compared to the null-hypothes
America, C.S. America: Central & South America.
Please cite this article as: Magiorkinis, G., et al., The global spread of HIV-1
dx.doi.org/10.1016/j.meegid.2016.05.041signiﬁcant outgoing events to any region). It receives infections from
all other regions except Asia (Table 1 – “Europe” column). The signiﬁ-
cant pathways towards Europe are also supported by high ratios of ob-
served over expected events indicating high levels of viral importation.
The American geographical regions were “outwards” of infections
exported to the rest of the world. North America was an “outward” of
viral migration to all regions except Asia (see Table 1 – “N. America”
row). Central/South America and the Caribbean were also found as di-
rect “outward” for viral spread to other areas; however the two path-
ways with the highest statistical signiﬁcance out of these regions were
from Central/South America to North America and from the Caribbean
to Europe. Viral importation to North America took place mostly from
Central/South America (supplemental information). Asia is the most
isolated area with the fewest signiﬁcant incoming and outgoing
destinations; it has connections only with Oceania and Central/South
America. The viral spread among those large geographic regions is illus-
trated in Fig. 2.
3.3.2. Different roles for Western and Central/Eastern Europe
SinceWestern and Central/Eastern Europe have quite distinct ep-
idemic histories, we repeated the statistical phylogeographic analy-
sis after splitting Europe accordingly (Fig. S1). Comparing this new
analysis with the one where Europe was not split, we see that the
viral spread remained robust. We found no statistically signiﬁcant
viral migration towards C.E. Europe (Table 2 – “C.E. Europe” column),d ratios of mean of observed over mean of expected events (2nd row, in italics) under
Caribbean Africa Asia Oceania Europe
40.03 28.16 38.79 30.81 291.17
1.85 3.01 0.89 2.49 4.16
7.88 3.70 8.29 5.50 42.22
2.36 2.23 1.20 2.98 5.95
1.37 0.78 0.84 5.06
5.80 0.70 2.43 6.05
0.25 0.16 0.10 0.75
2.25 0.85 1.73 8.13
1.20 1.01 3.06 3.67
0.41 0.78 1.74 0.67
0.50 0.07 1.14 1.19
2.91 1.31 2.94 5.73
24.36 28.04 19.46 21.76
0.12 0.33 0.05 0.20
is of panmixis) after Bonferroni correction for multiple comparisons. N.·America: North
subtype B epidemic, Infection, Genetics and Evolution (2016), http://
Table 2
Means of observed migration events (1st row) across all bootstrap trees for each pathway and ratios of mean of observed over mean of expected events (2nd row, in italics) under geo-
graphic grouping strategy 2.
Importing to
N.·America C.S. America Caribbean Africa Asia Oceania C.E. Europe W. Europe
Exporting from N.·America 186.06 42.37 29.95 41.35 32.81 54.13 287.58
2.56 1.20 2.03 0.60 1.65 0.61 2.51
C.S. America 25.79 8.12 3.97 8.69 5.70 7.90 41.54
1.67 1.70 1.87 0.90 1.97 0.65 3.62
Caribbean 1.43 2.17 1.38 0.78 0.85 0.29 5.04
0.60 1.21 3.22 0.48 1.71 0.15 3.42
Africa 0.57 0.62 0.27 0.16 0.11 0.29 0.76
1.74 2.74 2.23 0.76 2.25 1.06 4.30
Asia 1.86 2.68 1.22 1.02 3.08 0.30 3.64
1.40 0.31 0.29 0.55 1.21 0.03 0.37
Oceania 0.46 0.66 0.52 0.08 1.16 0.45 1.16
0.68 1.43 2.60 1.36 2.56 0.88 2.85
C.E. Europe 1.92 1.47 1.22 0.24 0.57 0.49 25.88
0.07 0.08 0.14 0.06 0.03 0.09 1.14
W. Europe 109.53 78.35 18.75 23.51 14.62 16.30 162.36
0.22 0.28 0.14 0.42 0.06 0.22 0.47
Note. Cells in bold indicate statistically signiﬁcant pathways (compared to the null-hypothesis of panmixis) after Bonferroni correction formultiple comparisons. N.·America: North Amer-
ica, C.S. America: Central & South America, C.E. Europe: Central/Eastern Europe, W. Europe: Western Europe.
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(Table 2 – “C.E. Europe” row). Thus, the high incoming viral spread
towards Europe (Table 1) observed in the global analysis is due to in-
coming spread particularly to Western Europe rather than to the
whole continent; while C.E. Europe seems to be isolated. Indeed,
the phylogeographic tree suggests that C.E. European strains seem
to accumulate in well-formed distinct clades (Figs. 1A, S2 in the sup-
plemental material), a pattern which suggests that they are more re-
lated with each other than with strains isolated in other parts of the
globe.
3.3.3. Viral spread among European countries
We then explored viral spread of the different European countries
separately in order to detect a ﬁner pattern of viral global spread, as
was the case for the West and C.E. Europe above. Results are in accor-
dancewith the above-mentioned pattern and indicate that C.E. EuropeanFig. 2. Global migration patterns of HIV-1 subtype B estimated by statistical phylogeography
(highlighted countries) from which HIV-1 sequences were available. Pins represent different
subtype B spread.
Please cite this article as: Magiorkinis, G., et al., The global spread of HIV-1
dx.doi.org/10.1016/j.meegid.2016.05.041countries seem to be more isolated (Table S2 in the supplemental mate-
rial, supplemental information). Some C.E. European countries such as
Albania, Romania and Belarus had fewer signiﬁcant migratory targets.
More speciﬁcally all countries in C.E. Europe were exchanging viruses
with a smaller number of countries (i.e. 1–8) in comparison to Western
Europe (i.e. 2–18) except for Poland and Czech Republic/Slovakia for
which we found a larger number of connecting countries (5–15) (Fig.
S3, Table S2 in the supplemental material).
Concerning viral spread among the European countries we ﬁnd evi-
dence that they were highly interconnected (Fig. S3B, supplemental in-
formation). Viral spread within Europe seems to be high. Some
countries like Portugal, Spain and Germany exchange HIV with many
other countries (Table S3 in the supplemental material). Within West-
ern Europe themost connected country seems to be Spain, both quanti-
tatively in migration events, and also in the number of countries with
signiﬁcant exchanges of infection (Fig. S3A,B).under the geographical grouping strategy 1. Colors indicate different geographic regions
geographic regions (group of highlighted countries) and arrows indicate the direction of
subtype B epidemic, Infection, Genetics and Evolution (2016), http://
7G. Magiorkinis et al. / Infection, Genetics and Evolution xxx (2016) xxx–xxx3.3.4. Quantiﬁcation of viral migration: “outwards”, “inwards” and “isolated”
regions
We introduced a simple metric (Force of Migration or FM, see
Materials and methods) to quantify if a geographical unit (whether it
is a region or a country) is actively spreading or passively receiving
viral migrations. FM is larger for geographic units that have more
exporting targets and associated exportingmigration events, and small-
er for geographic units that havemore importing targets and associated
migration events. We test the statistical signiﬁcance (corrected for
multiple comparisons with the Bonferroni formula) of FM for each
geographic unit against a simulated distribution assuming random
exporting and importing events. We categorize a geographical unit as
an “outward” if it spreads viral strains more than expected, “inward” if
it receives viral strains more than expected and “isolated” if it is
exchanging viral strains with other regions less than expected. We
comment on the most striking ﬁndings of FM from each of the above-
mentioned geographic segregations.
In the analysis wherewe considered Europe to be a single geograph-
ic region, N. America had (median) FM = 61.59 which is 113 times
higher than what expected by chance (expected FM = 0.543,
p b 0.001), so it is an “outward” of viral migration, Europe is a sink
FM = 0 much less than the expected value FM = 26.54, p b 0.001.
When we separate Europe into West and Central/East, N. America still
remains an “outward” (FM=58.67, 45 timeshigher, p b 0.001),Western
Europe remains a sink (FM=0, expected FM=12.62, p b 0.001), but C.E.
Europe is “isolated”with no signiﬁcant exporting or importing viral mi-
gration. We note that FM cannot be determined for “isolated” regions
due to zeros in both nominator and denominator, but the statistical sig-
niﬁcance for being “isolated” can be estimated by comparing the distri-
bution of the non-signiﬁcant events in the observed against the
simulated trees. We found that 247 out of 250 trees showed no signiﬁ-
cant migrations in the observed dataset (i.e. the phylogenetic trees of
the bootstrapped alignment), while only 19 out of 250 simulated trees
had no signiﬁcant events (p b 0.001, signiﬁcant for multiple testing).
To address whether the above pattern for N. America is biased by
earlier sampling dates for N. American strains, we repeated the same
analysis (with Europe as a single region) on a dataset where we ran-
domly subsampled sequences to keep the ratio of European to N. Amer-
ican isolates at 2:1 for each sampling year (i.e. to keep roughly the same
overall ratio as in the large dataset). The N. American FM was smaller
than when we do not account for sampling date, but still much higher
than expected (28 times, p b 0.001); same for the European FM = 0
(again much lower than expected, p b 0.001). Thus, the observed
pattern of N. America being an outward and Europe being an inward
is robust with respect to sampling date.
3.4. Exceptions to the Western European “sink”
Since Western Europe was found to be a sink, we analysed whether
there are any countries within Western Europe deviated from this pat-
tern i.e. are more connected to non-European countries. We made an
index that is equal to the ratio of the observed total migration events
(importing and exporting) to non-European divided by the total migra-
tion events to European regions. This ratio if larger than 1 indicates
that a country ismore connected to non-European countries than to Eu-
ropean ones and can be tested for its statistical signiﬁcance against the
ratio expected by chance with a standard non-parametric test (Mann–
Whitney test to compare observed against expected). Three countries
were found to have a large signiﬁcant ratio, more speciﬁcally the United
Kingdom (ratio = 1.8), Switzerland (ratio = 1.6) and France (ratio =
1.5) (all having p b 0.001, signiﬁcant formultiple comparisons) (Fig. S4).
3.5. Dating the establishment of epidemics in the C.E. European “isolation”
Even though C.E. Europe was found to be “isolated” it must have
been seededwith subtype B at some point in time. We, thus, performedPlease cite this article as: Magiorkinis, G., et al., The global spread of HIV-1
dx.doi.org/10.1016/j.meegid.2016.05.041phylodynamic analysis in ﬁvemajormonophyletic clusters from this re-
gion. These clusters consisted of 10, 21, 38, 67 and 230 sequences from
Slovenia (cluster I), Slovenia/Bulgaria (cluster II), Slovenia (cluster III),
Romania (cluster IV), and Poland/Bulgaria/Ukraine (cluster V), respec-
tively. The estimated time of the most recent common ancestor
(tMRCA) corresponding approximately to the time of the origin of
HIV-1 epidemic in these areas ranged between 1987 and 2001 (median
estimates). Cluster I was estimated to be the most recent, with estimat-
ed tMRCA in 2001 (median value, 95% Higher Posterior Density HPD:
1999–2003). For clusters II and III tMRCA was estimated in 1989 (95%
HPD: 1984–1993) and 1996 (95% HPD: 1992–1999), respectively. For
the largest one (cluster V) including HIV-1 sequences from Poland,
Bulgaria and Ukraine the tMRCA was in 1987 (95% HPD: 1982–1990).
Finally for cluster IV fromRomania the date of themost recent common
ancestor was previously estimated in 1991 (95%HPD: 1983–1999)
(Stanojevic et al., 2012).
3.6. Viral migration is epidemiologically consistent
As a ﬁnal step of our analyses we wished to evaluate whether viral
migration, as we quantiﬁed it with statistical phylogeography, is consis-
tent with known epidemiologic surveillance. Standard mathematical
models predict that transmission is higher in populationswithmore in-
fected individuals suggesting that countries with higher number of in-
fected persons should drive viral migration to other countries or, in
other words, be more prone to a spillover effect (Anderson and May,
1991; Grassly and Fraser, 2008; Keeling and Rohani, 2008). Thus, we
would expect countries with higher number of prevalent cases to be
more likely to provide spillovers to other countries. To examine wheth-
er our analyses is consistent with this expectation, we estimated the
country-speciﬁc number of HIV subtype B infections by multiplying
the total number of people living with HIV-1 per country until 2011,
based on the UNAIDS ﬁgures (www.unaids.org), by the percentage of
subtype B in each country (Abecasis et al., 2013; Avi et al., 2009;
Balode et al., 2012; Ciccozzi et al., 2005; Ivanov et al., 2013; Saad et al.,
2006; Stanojevic et al., 2012; Ustina et al., 2001). We then examined
the association between the number of HIV subtype B infections per
country/region and the number of countries that each country/region
exported viral strains in analysis (4) by running a regression analysis.
We log-transformed the number of subtype B infections per country/re-
gion because its distribution among countries/regions is skewed; 6 out
of 24 countries/regions with the most HIV-1 subtype B prevalent cases
(these are UK, France, Italy/Ireland, Spain, Ukraine, Germany) account
for more than 80% of the subtype B infections in Europe as a typical
long-tail distribution.
The number of exporting countries signiﬁcantly correlates with the
number of subtype B infections in the outward country (R2 = 0.40,
p b 0.001 and p=0.002 using the nonparametric Spearman correlation
coefﬁcient), suggesting (as expected) that areas with high number of
HIV prevalent cases are more likely to export infections to other coun-
tries (Fig. 3A). The correlation is robust against the number of sequences
sampled per country (i.e. it is not the result of includingmore sequences
from countries with higher prevalence). Germany, Italy/Ireland and
Spain have the higher number of exporting targets but also account
for more than 44% of the HIV-1 subtype B infections in Europe. To test
if these countries are inﬂuential points for the correlation, we removed
them from the regression analysis and the relationship between num-
ber of exporting countries and number of prevalent cases within the
outward country is weaker, but still highly signiﬁcant (R2 = 0.26, p=
0.015 and using Spearman rs = 0.58, p= 0.004). To take into account
the dissimilarities between Eastern and Western Europe we add a
dummy variable in the above regressionmodel indicating if the country
belongs to Central/Eastern or Western Europe (according to WHO
criteria). The analysis suggested that the number of prevalent cases in-
deed remained a signiﬁcant predictor (p=0.004). Crucially, the scatter
plot (Fig. 3A) suggested that UK and France lie far from the regressionsubtype B epidemic, Infection, Genetics and Evolution (2016), http://
Fig. 3.A: Scatter plot of the total number ofHIV-1 subtype B infected individuals in log scale per country/region versus thenumber of exporting pathways for each country/region. The solid
line is the ﬁtted regression line. R2 is the coefﬁcient of determination and p is the p-value of the regressionmodel. Country names are shown only for the statistically signiﬁcant regression
in ISO (International Organization for Standardization) three-letter codes; ALB: Albania, AUT: Austria, BEL: Belgium, BGR: Bulgaria, BLR: Belarus, CHE: Switzerland, CZE: Czech Republic,
DEU: Germany, DNK: Denmark, ESP: Spain, EST: Estonia, FIN: Finland, FRA: France, GBR: United Kingdom, GRC: Greece, IRL: Ireland, ISR: Israel, ITA: Italy, LTV: Latvia, LUX: Luxembourg,
NLD: Netherlands, NOR: Norway, POL: Poland, PRT: Portugal, ROU: Romania, SRB: Serbia, SVK: Slovakia, SVN: Slovenia, SWE: Sweden, UKR: Ukraine. B: Same as A, but with the number of
importing pathways for each country/region.
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Europe as it would be expected from their high number of prevalent
cases. Removal of UK and France from the analysis dramatically im-
proves the correlation (R2 = 0.69, p b 0.001 or Spearman rs = 0.83,
p b 0.001) suggesting that UK and France had a different spillover pat-
tern than the rest of the European countries. We found no signiﬁcant
correlation between the number of prevalent caseswithin a country/re-
gion and the number of countries which are source of viral introduction
to that country/region (R2 = 0.03, p= 0.47, Fig. 3B).
4. Discussion
Our study describes the global pattern of HIV-1 migration across the
Western Hemisphere. Molecular methods have been extensively used
for the characterization of the HIV-1 migration; however, the global
routes of epidemic migration remain uncovered. In our study, we used
a global dataset collected after a systematic bibliographic search, and
the inference of cross-border transmissions was based on statisticalPlease cite this article as: Magiorkinis, G., et al., The global spread of HIV-1
dx.doi.org/10.1016/j.meegid.2016.05.041phylogeographic approach as described previously (Angelis et al.,
2015; Cottam et al., 2008; Magiorkinis et al., 2009; Paraskevis et al.,
2009, 2013;Wallace et al., 2007).Moreoverwe developed a newmetric
for the classiﬁcation of geographic areas as “outward”, “inward” and
“isolated” according to their estimated pattern of incoming or outgoing
viral spread pattern.
We found that the American continent and the Caribbean acted as
“outwards” for theWestern epidemic not only at the initial randommi-
gration event (Gilbert et al., 2007), but also through constant subse-
quent spread to the rest of the world. The striking role of America in
disseminating subtype B infections was probably a consequence of the
early introduction and propagation of this clade in North America re-
maining silent for almost a decade (Gilbert et al., 2007).
In striking contrast, subtype B infections in Europe, and speciﬁcally
in Western Europe, were introduced as a result of multiple introduc-
tions from different geographic areas. This is in accordance with previ-
ous studies suggesting that many of the earliest HIV(+) cases in
Europe among the MSM had links to N. America (Pinching, 1984), andsubtype B epidemic, Infection, Genetics and Evolution (2016), http://
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curred among MSM in the UK (Hue et al., 2005) and in injecting drug
users in Northern Europe (Lukashov et al., 1996). Our study adds a
piece in the puzzle with regard to the HIV-1 global migration patterns.
The HIV-1 epidemic was documented ﬁrst among theMSM in the Unit-
ed States, in early eighties, as the result of an early introduction from the
Haiti (Gilbert et al., 2007). Subsequently, the epidemic spread to Europe
and other areas in the Western Hemisphere, however until now the
question with regard to the patterns of cross-continental transmissions
of the currently circulating strains remains unanswered. Our study
describes the distinct role of different geographic areas in driving the
Western epidemic, highlighting that the role of Europe for this
subepidemic with respect to the rest of the globe was secondary and
the incoming infections spreadmainly among regional populations. Ad-
ditionally we show that viral spread to Northern America occurred
mostly from Central/South America; Asia on the other hand, was the
most isolated area. The former can be explained by cross-border move-
ments of people across the American continent, while the “isolated”
nature of subtype B epidemic in Asia, previously described as themono-
phyletic clade “B′”, is probably due to the local spread of this clade
among the intravenous drugs users (IDU) and former plasma donors
(FPDs) in Asia (Li et al., 2010).
After separating Europe we show that C.E. Europe did not import
more than expected fromWestern Europe even thoughWestern Europe
had historically higher levels of subtype B infection which might be ex-
plained due to the historically low population mobility among these re-
gions of Europe. We estimated the date of this clear phylogeographic
segregation of West and C.E. European strains by means of molecular
clock analysis to be roughly between late 80s and late 90s, which is
around the separation of the post-Soviet countries. With regard to C.E.
Europe, the viral spread pattern can be characterized as “isolated”. A
similar pattern has also been detected for the subtype A spreading
among the local IDU population (AFSU) in Easter Europe (Bobkov et al.,
1998; Thomson et al., 2009), showing almost no links with other geo-
graphic areas. The similarity in the “isolated” pattern of viral migration
in Eastern Europe for both subtypes A and B, although that they have
spread through different routes (parenteral and sexual transmissions),
strongly suggest that factors like limited population mobility and high
risk behavior of drug injectors have played a signiﬁcant role in shaping
the characteristics of HIV-1 epidemic spread in Eastern Europe that re-
mains isolated.We also see that C.E Europe provided sources of viralmi-
gration towards Western Europe; speciﬁcally Poland and the Czech
Republic showed more connectivity to Western European countries,
than the rest of the C.E. European countries (Figs. S5 and S6 in the sup-
plemental material). Poland was the ﬁrst country that loosened its ties
from the Eastern European block, which could probably explain its clos-
er tieswithWestern Europe than the other former communist countries
in C.E. Europe. Similarly Czech Republic had always been in closer con-
nection to Western Europe in comparison to other Eastern European
countries mainly due to its central position in Europe.We, thus, suggest
that the viral migration pattern between Western and C.E. Europe can
be also explained as a result of the separation of these two parts of
Europe from the end of World War II in 1947 till the end of Cold War
in 1989 (Hansen, 2002). Soon after the split of the Soviet Union
humanmigrations from Eastern European countries toWestern Europe
was notable, and this is mirrored by the recent introduction of Eastern
European isolates in Western European Countries.
It is noteworthy that the highest spread between any European
country and non-European regions was observed for UK, Switzerland
and France (Fig. S4 in the supplemental material). UK and France
show similar patterns with connections to Americas and Africa and we
have also found that for the correlation between number of prevalent
cases and number of signiﬁcant migratory routes, UK and France had a
striking deviation. This is in accordance with our ﬁndings that both
these countries provide major sources of viral spread from outside
Europe (North, Central & South America and Caribbean), suggestingPlease cite this article as: Magiorkinis, G., et al., The global spread of HIV-1
dx.doi.org/10.1016/j.meegid.2016.05.041the distinct nature of these countries with regards to epidemic spread
in Europe. UK and France are two of the largest countries in Europe
with signiﬁcant social and economic links across the globe that may ex-
plain their central role as epidemic importers.
Switzerland had also high connectivity with non-European coun-
tries, but shows a different pattern than UK and France. It did not devi-
ate as strikingly as UK and France from the regression line between the
number of prevalent cases and the number of signiﬁcant migratory
routes within Europe (Fig. 3A). Our ﬁndings are in accordance with a
previous study suggesting that sequences from MSM clustered within
local transmission networks at low proportions, suggestingmultiple in-
troductions from abroad (Kouyos et al., 2010).
Considering HIV spread among European countries, the seemingly
most inﬂuential (both as exporter and importer) in accordance with
previous studies (Paraskevis et al., 2009) is Spain (Fig. S3) having
many signiﬁcant viral exchange routes with other European countries.
Several factorsmight have contributed to this,ﬁrst Spain has the highest
number of HIV-1 subtype B infections, thus ismore likely to spill-over to
other countries. Its high connectivity might be connected with the fact
that within the last part of the 20th century, although the unemploy-
ment rate has been continuously high, Spain experienced a rapidmigra-
tion turnover from a traditional exporter to a signiﬁcant immigration
destination (Bentolila et al., 1990). Being also among the most popular
tourist destinations is likely to have contributed to the observed pattern
(Paraskevis et al., 2009).
Notably, we found that the exporting viral spread, as measured by
the number of exporting countries within Europe, correlates with the
number of infections due to subtype B in the source country. We, thus,
suggest that in general higher prevalent countries are more likely to
act as sources for cross-border infections within Europe.
Since our study is retrospective, it is unlikely to provide strong evi-
dence for causality in viral migration. Based on the inferred global pat-
tern of HIV-1 subtype B viral spread, we may hypothesize that the
outgoing viral spread for N. America and the Caribbean was probably
due to cross-border transmissions occurred at the early stage of the ep-
idemicwhen itwas silent; a hypothesis further supported by theﬁnding
that viral lineages from N. America branched close to root of the tree.
Central & South America show themost extensive network for outgoing
spread probably due to immigration originated from these areas. In
sticking contrast, Europewas an inward over the course of the epidemic,
suggesting signiﬁcant domestic migration for this subepidemic. Finally,
Asiawas themost isolated due to speciﬁcwayofHIV-1 subtype Bmigra-
tion among the local networks of IDU and FPDs. Therefore the global
spread of subtype B was not random but differs signiﬁcantly across
the continents.
Many mathematical models can predict the potential of patho-
gens to successfully establish an epidemic based on transmission pa-
rameters (Anderson and May, 1991; Grassly and Fraser, 2008;
Keeling and Rohani, 2008). Theory suggests that epidemics during
their early stages are sensitive to stochastic effects due to the small
number of infected individuals (Bailey, 1953); presumably the
route taken by the initial migration of HIV-1 from Africa to the US
is the initial less predictable stochastic event. As pathogens become
more prevalent (i.e. infect a larger proportion of the population) the
overall dynamics operate in approximately deterministic way
(Whittle, 1955); accordingly we show that European countries with
higher HIV subtype B burden are more likely to spill infections over
other countries. We, thus, show that the global viral phylogeography
of HIV subtype B was not random and suggest that, since major land-
marks of the last part of the 20th century inﬂuence human (hence
virus) mobility, the virus spread around the globe is largely the result
of natural virus-host ecological dynamics. Thus, our study provides
working hypotheses as to how socio-economic circumstances inﬂuence
the human-virus ecological dynamics and advocates in support of scal-
ing-up collaboration of health system for preventing the spread of
chronic viral infections.subtype B epidemic, Infection, Genetics and Evolution (2016), http://
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One major limitation of our study is that the collection of the sam-
ples/molecular sequences has not been performed under a common
framework, which might make our analyses prone to sampling bias.
To the best of our knowledge this drawback is present in all the phylo-
geographic studies published for HIV-1 up to date, as a systematic col-
lection of sequences on large geographic areas has not been performed.
However, here for the ﬁrst time we have systematically approached
the sampling bias problem in multiple levels including our design and
analyses by: 1) using sequences collected within well-deﬁned cohorts
allowing for uniformity of inclusion criteria at least within Europe, 2)
collecting sequences with a meta-analyses approach rather than se-
quence database download for the non-European datasets, again
allowing for more uniformity of inclusion criteria, and 3) analysing 2
sub-datasets to show robustness of results against potential sampling
bias. We ﬁnd no evidence of sampling bias in our analysis and we
argue that includes the most representative and systematically com-
posed sequence dataset that has been used for phylogeography studies
of HIV-1 up to date.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.meegid.2016.05.041.
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